Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases.

Air pollution Asthma Chronic respiratory diseases Guidelines Integrated care pathways Rhinitis Vilnius Declaration mHealth

Journal

Clinical and translational allergy
ISSN: 2045-7022
Titre abrégé: Clin Transl Allergy
Pays: England
ID NLM: 101576043

Informations de publication

Date de publication:
2019
Historique:
received: 08 10 2018
accepted: 04 01 2019
entrez: 2 2 2019
pubmed: 2 2 2019
medline: 2 2 2019
Statut: epublish

Résumé

Over 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontrolled and the cost of inaction is unacceptable. A meeting was held in Vilnius, Lithuania (March 23, 2018) under the patronage of the Ministry of Health and several scientific societies to propose multisectoral care pathways embedding guided self-management, mHealth and air pollution in selected chronic respiratory diseases (rhinitis, chronic rhinosinusitis, asthma and COPD). The meeting resulted in the Vilnius Declaration that was developed by the participants of the EU Summit on chronic respiratory diseases under the leadership of Euforea. The Vilnius Declaration represents an important step for the fight against air pollution in chronic respiratory diseases globally and has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge.

Sections du résumé

BACKGROUND BACKGROUND
Over 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontrolled and the cost of inaction is unacceptable. A meeting was held in Vilnius, Lithuania (March 23, 2018) under the patronage of the Ministry of Health and several scientific societies to propose multisectoral care pathways embedding guided self-management, mHealth and air pollution in selected chronic respiratory diseases (rhinitis, chronic rhinosinusitis, asthma and COPD). The meeting resulted in the Vilnius Declaration that was developed by the participants of the EU Summit on chronic respiratory diseases under the leadership of Euforea.
CONCLUSION CONCLUSIONS
The Vilnius Declaration represents an important step for the fight against air pollution in chronic respiratory diseases globally and has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge.

Identifiants

pubmed: 30705747
doi: 10.1186/s13601-019-0242-2
pii: 242
pmc: PMC6348633
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

7

Commentaires et corrections

Type : ErratumIn

Références

Philos Public Aff. 1978 Summer;7(4):370-90
pubmed: 11664929
J Appl Physiol (1985). 2005 Apr;98(4):1154-62
pubmed: 15772055
Clin Exp Allergy. 2005 Jun;35(6):728-32
pubmed: 15969662
J Allergy Clin Immunol. 2006 Jan;117(1):158-62
pubmed: 16387600
Thorax. 2006 Aug;61(8):663-70
pubmed: 16877690
Allergy. 2007 Mar;62(3):216-23
pubmed: 17298337
Chest. 2007 May;131(5):1557-66
pubmed: 17494805
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
Allergy. 2008 Jun;63(6):634-45
pubmed: 18445181
J Clin Nurs. 2008 Nov;17(21):2935-44
pubmed: 19034992
Eur Respir J. 2010 Mar;35(3):515-21
pubmed: 19643941
Thorax. 2010 Jan;65(1):14-20
pubmed: 19729360
Rhinology. 2010 Jun;48(2):201-5
pubmed: 20502761
J Allergy Clin Immunol. 2010 Sep;126(3):466-76
pubmed: 20816182
Pediatr Allergy Immunol. 2011 Jun;22(4):388-92
pubmed: 21261745
Prim Care Respir J. 2011 Jun;20(2):178-83
pubmed: 21431275
Genome Med. 2011 Jul 06;3(7):43
pubmed: 21745417
N Engl J Med. 2012 Mar 1;366(9):780-1
pubmed: 22375967
Lancet. 2012 Mar 31;379(9822):e45-6
pubmed: 22464390
Allergy. 2012 Jun;67(6):726-31
pubmed: 22540290
Thorax. 2013 Apr;68(4):380-4
pubmed: 22781122
Asia Pac Allergy. 2012 Oct;2(4):275-9
pubmed: 23130334
Am J Respir Crit Care Med. 2013 Jan 1;187(1):42-8
pubmed: 23155143
Allergy. 2013;68(5):555-61
pubmed: 23855711
BMJ. 1990 Aug 4;301(6746):259-62
pubmed: 2390618
Eur Respir J. 2013 Sep;42(3):559-63
pubmed: 24000245
J Occup Environ Med. 2014 Oct;56 Suppl 10:S49-54
pubmed: 25285977
Thorax. 2015 Jun;70(6):595-7
pubmed: 25616486
Int Arch Allergy Immunol. 2015;166(3):231-40
pubmed: 25924687
Int Arch Allergy Immunol. 2015;167(1):57-64
pubmed: 26184344
Eur Respir Rev. 2015 Sep;24(137):474-83
pubmed: 26324809
Allergy. 2016 May;71(5):583-7
pubmed: 26660289
COPD. 2016 Jun;13(3):372-9
pubmed: 26683097
Dtsch Arztebl Int. 2015 Dec 21;112(51-52):878-83
pubmed: 26900154
Am J Respir Crit Care Med. 2016 Aug 15;194(4):429-38
pubmed: 26950751
BMC Public Health. 2016 Jul 15;16:572
pubmed: 27417513
Curr Opin Allergy Clin Immunol. 2016 Oct;16(5):421-6
pubmed: 27490122
Curr Opin Allergy Clin Immunol. 2016 Oct;16(5):434-40
pubmed: 27518837
J Allergy Clin Immunol. 2017 Feb;139(2):408-414.e2
pubmed: 27979429
Thorax. 2017 Apr;72(4):295-296
pubmed: 28104829
BMJ Open. 2017 Jan 24;7(1):e013935
pubmed: 28119390
Ann Allergy Asthma Immunol. 2017 Mar;118(3):269-275
pubmed: 28143681
BMJ Qual Saf. 2017 Sep;26(9):722-733
pubmed: 28174319
Lancet. 2017 May 13;389(10082):1907-1918
pubmed: 28408086
Eur Respir J. 2017 May 1;49(5):
pubmed: 28461306
Clin Transl Allergy. 2017 Jun 1;7:17
pubmed: 28572918
J Allergy Clin Immunol. 2017 Oct;140(4):950-958
pubmed: 28602936
Eur Respir J. 2017 Jun 22;49(6):
pubmed: 28642312
Clin Transl Allergy. 2017 Jul 12;7:22
pubmed: 28706720
Chron Respir Dis. 2017 Aug;14(3):276-288
pubmed: 28774200
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1274-1286.e9
pubmed: 29017832
Respirology. 2018 Jan;23(1):14-15
pubmed: 29052301
J Allergy Clin Immunol. 2017 Dec;140(6):1683-1692
pubmed: 29080787
Ann Allergy Asthma Immunol. 2017 Dec;119(6):489-511.e41
pubmed: 29103802
Environ Prog Sustain Energy. 2017 Jul;36(4):982-988
pubmed: 29238442
Clin Transl Allergy. 2017 Dec 27;7:49
pubmed: 29299230
Eur Respir J. 2018 Jan 11;51(1):
pubmed: 29326333
Allergy. 2018 Sep;73(9):1763-1774
pubmed: 29336067
NPJ Prim Care Respir Med. 2018 Jan 17;28(1):2
pubmed: 29343739
J Allergy Clin Immunol. 2018 Mar;141(3):878-879
pubmed: 29410333
N Engl J Med. 2018 May 17;378(20):1877-1887
pubmed: 29768147
Clin Transl Allergy. 2018 Jun 25;8:25
pubmed: 29983907
Clin Transl Allergy. 2018 Jul 9;8:23
pubmed: 30002811
Clin Transl Allergy. 2018 Sep 17;8:36
pubmed: 30237869
J Allergy Clin Immunol. 2018 Sep 29;:null
pubmed: 30273709
Clin Transl Allergy. 2018 Oct 25;8:45
pubmed: 30386555
Allergy. 2018 Dec 18;:null
pubmed: 30565275
BMJ. 1998 Jan 10;316(7125):133-7
pubmed: 9462322

Auteurs

A Valiulis (A)

1Department of Public Health, Clinic of Children's Diseases, and Institute of Health Sciences, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.

J Bousquet (J)

3MACVIA-France, Fondation partenariale FMC VIA-LR, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
INSERM U 1168, VIMA : Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France.
5UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.
Euforea, Brussels, Belgium.
7Charité, Berlin, Germany.

A Veryga (A)

Minister of Health, Vilnius, Lithuania.

U Suprun (U)

Minister of Health, Kiev, Ukraine.

D Sergeenko (D)

Minister of Labour, Health and Social Affairs, Tbilisi, Georgia.

S Cebotari (S)

Minister of Health, Labour and Social Protection, Chișinău, Moldova.

D Borelli (D)

European Parliament, Perugia, Italy.

S Pietikainen (S)

European Parliament, Helsinki, Finland.

J Banys (J)

Lithuianian Academy of Sciences, Vilnius, Lithuania.

I Agache (I)

15Faculty of Medicine, Transylvania University, Brasov, Romania.

N E Billo (NE)

Global Alliance Against Chronic Respiratory Diseases (GARD), Joensuu, Finland.

A Bush (A)

17Imperial College and Royal Brompton Hospital, London, UK.

I Chkhaidze (I)

18Department of Pediatrics, and Iashvili Central Children's Hospital, Tbilisi State Medical University, Tbilisi, Georgia.

L Dubey (L)

19Faculty of Postgraduate Education, Lviv National Medical University by Danylo Halytsky, Lviv, Ukraine.

W J Fokkens (WJ)

20Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands.

J Grigg (J)

21Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK.

T Haahtela (T)

22Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

K Julge (K)

23Children's Clinic, Tartu University Institute of Clinical Medicine, Tartu, Estonia.

O Katilov (O)

Vinnytsa National Medical University by Mykola Pyrogov, Vinnytsa, Ukraine.

N Khaltaev (N)

Global Alliance Against Chronic Respiratory Diseases (GARD-WHO), Geneva, Switzerland.

M Odemyr (M)

26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.

S Palkonen (S)

26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.

R Savli (R)

26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.

A Utkus (A)

27Department of Human and Medical Genetics, Institute of Biomedical Sciences, Vilnius University Faculty of Medicine, Vilnius, Lithuania.
Association of Medical Schools in Europe, Berlin, Germany.

V Vilc (V)

State Institute of Phtysiopulmonology by Chiril Draganiuk, Chisinau, Moldova.

T Alasevicius (T)

1Department of Public Health, Clinic of Children's Diseases, and Institute of Health Sciences, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.

A Bedbrook (A)

3MACVIA-France, Fondation partenariale FMC VIA-LR, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.

M Bewick (M)

iQ4U Consultants Ltd, London, UK.

J Chorostowska-Wynimko (J)

31Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

E Danila (E)

32Clinic of Chest Diseases, Immunology and Allergology, Centre of Pulmonology and Allergology, Institute of Clinical Medicine, Vilnius University Medical Faculty, Vilnius, Lithuania.

A Hadjipanayis (A)

33Medical School, European University of Cyprus, Nicosia, Cyprus.

R Karseladze (R)

34Tbilisi State University Faculty of Medicine, Tbilisi, Georgia.

V Kvedariene (V)

35Clinic of Infectious Chest Diseases, Dermatology and Allergology, Institute of Biomedical Sciences, Institute of Clinical Medicine, Vilnius University Faculty of Medicine, Vilnius, Lithuania.

E Lesinskas (E)

36Clinic of ENT and Eye Diseases, Institute of Clinical Medicine, Vilnius University Medical Faculty, Vilnius, Lithuania.

L Münter (L)

Danish Commitee for Health Education, Copenhagen East, Denmark.

B Samolinski (B)

38Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.

S Sargsyan (S)

39Institute of Child and Adolescent Health at Arabkir Medical Centre, Yerevan State Medical University, Yerevan, Armenia.

B Sitkauskiene (B)

40Department of Immunology and Allergology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.

D Somekh (D)

European Health Futures Forum (EHFF), Dromahair, Ireland.

L Vaideliene (L)

42Clinic of Children's Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.

A Valiulis (A)

43Department of Rehabilitation, Physical and Sports Medicine, Institute of Health Sciences, Vilnius University Medical Faculty, Vilnius, Lithuania.

P W Hellings (PW)

Euforea, Brussels, Belgium.
44Department of Otorhinolaryngology, University Hospital Leuven, Leuven, Belgium.
45Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Classifications MeSH